 Maria Frank
Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemorrhagic Fever, Crimean | 3 | 2024 | 10 | 2.570 |
Why?
| | Hemorrhagic Fever Virus, Crimean-Congo | 3 | 2024 | 12 | 2.560 |
Why?
| | Viral Vaccines | 2 | 2024 | 107 | 0.820 |
Why?
| | Antiviral Agents | 3 | 2024 | 746 | 0.720 |
Why?
| | Hemorrhagic Fever, American | 1 | 2021 | 2 | 0.700 |
Why?
| | Arenaviridae | 1 | 2021 | 12 | 0.690 |
Why?
| | Disaster Planning | 1 | 2022 | 97 | 0.670 |
Why?
| | Disasters | 1 | 2022 | 99 | 0.670 |
Why?
| | Hospital Medicine | 1 | 2022 | 92 | 0.650 |
Why?
| | Hospitalists | 2 | 2020 | 251 | 0.570 |
Why?
| | Ticks | 2 | 2024 | 29 | 0.430 |
Why?
| | Hemorrhagic Fevers, Viral | 2 | 2024 | 16 | 0.420 |
Why?
| | Physicians, Primary Care | 1 | 2017 | 225 | 0.420 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 339 | 0.410 |
Why?
| | Qualitative Research | 1 | 2017 | 1525 | 0.300 |
Why?
| | Substance-Related Disorders | 1 | 2017 | 1093 | 0.270 |
Why?
| | Hospitals | 2 | 2022 | 694 | 0.220 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2022 | 78 | 0.180 |
Why?
| | Humans | 16 | 2024 | 140898 | 0.180 |
Why?
| | Communicable Diseases | 1 | 2023 | 161 | 0.170 |
Why?
| | Virus Replication | 1 | 2024 | 531 | 0.170 |
Why?
| | Disease Management | 1 | 2024 | 628 | 0.160 |
Why?
| | Animals | 3 | 2024 | 37579 | 0.130 |
Why?
| | Hospitals, University | 2 | 2015 | 175 | 0.130 |
Why?
| | Commerce | 1 | 2017 | 72 | 0.120 |
Why?
| | Telephone | 1 | 2016 | 180 | 0.120 |
Why?
| | Patients | 1 | 2017 | 179 | 0.120 |
Why?
| | Aftercare | 1 | 2016 | 218 | 0.110 |
Why?
| | Authorship | 1 | 2015 | 43 | 0.110 |
Why?
| | Sexism | 1 | 2015 | 68 | 0.110 |
Why?
| | Continuity of Patient Care | 1 | 2016 | 284 | 0.100 |
Why?
| | Clothing | 1 | 2013 | 22 | 0.100 |
Why?
| | Bacterial Load | 1 | 2013 | 67 | 0.100 |
Why?
| | Equipment Contamination | 1 | 2013 | 71 | 0.100 |
Why?
| | Learning | 1 | 2017 | 434 | 0.100 |
Why?
| | Adenosine Monophosphate | 2 | 2022 | 73 | 0.090 |
Why?
| | Physician-Patient Relations | 1 | 2017 | 580 | 0.090 |
Why?
| | Alanine | 2 | 2022 | 158 | 0.090 |
Why?
| | Faculty, Medical | 1 | 2015 | 292 | 0.090 |
Why?
| | Leadership | 1 | 2015 | 391 | 0.080 |
Why?
| | Anti-Infective Agents | 1 | 2013 | 239 | 0.080 |
Why?
| | Disease Outbreaks | 2 | 2024 | 418 | 0.080 |
Why?
| | Patient Discharge | 1 | 2016 | 930 | 0.080 |
Why?
| | Referral and Consultation | 1 | 2012 | 794 | 0.060 |
Why?
| | Health Personnel | 1 | 2013 | 724 | 0.060 |
Why?
| | Sudan | 1 | 2024 | 4 | 0.060 |
Why?
| | Attitude of Health Personnel | 1 | 2012 | 1175 | 0.050 |
Why?
| | Pandemics | 2 | 2023 | 1643 | 0.050 |
Why?
| | Adaptive Clinical Trials as Topic | 1 | 2022 | 25 | 0.050 |
Why?
| | Clinical Trials, Phase III as Topic | 1 | 2022 | 111 | 0.050 |
Why?
| | Patient Isolation | 1 | 2022 | 18 | 0.050 |
Why?
| | Prospective Studies | 4 | 2016 | 7749 | 0.050 |
Why?
| | Infection Control | 1 | 2022 | 165 | 0.040 |
Why?
| | Dexamethasone | 1 | 2022 | 379 | 0.040 |
Why?
| | Patient Care Team | 1 | 2024 | 664 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2022 | 1978 | 0.030 |
Why?
| | Oxygen | 1 | 2022 | 992 | 0.030 |
Why?
| | Critical Care | 1 | 2022 | 650 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2022 | 1598 | 0.030 |
Why?
| | Efficiency | 1 | 2015 | 101 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2013 | 123 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2016 | 690 | 0.020 |
Why?
| | Hospitals, Urban | 1 | 2012 | 137 | 0.020 |
Why?
| | Quality Assurance, Health Care | 1 | 2012 | 318 | 0.020 |
Why?
| | Interprofessional Relations | 1 | 2012 | 282 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2022 | 11125 | 0.020 |
Why?
| | Adult | 2 | 2022 | 39134 | 0.020 |
Why?
| | Cohort Studies | 1 | 2016 | 5789 | 0.010 |
Why?
| | United States | 1 | 2022 | 15195 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2016 | 7899 | 0.010 |
Why?
| | Colorado | 1 | 2012 | 4597 | 0.010 |
Why?
| | Young Adult | 1 | 2016 | 13646 | 0.010 |
Why?
| | Male | 2 | 2016 | 69893 | 0.010 |
Why?
| | Female | 2 | 2016 | 75540 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2015 | 16315 | 0.010 |
Why?
| | Aged | 1 | 2016 | 24666 | 0.010 |
Why?
| | Middle Aged | 1 | 2016 | 34487 | 0.010 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|